EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

The pathogenic role of the immune system in erectile dysfunction and Peyronie’s disease: focusing on immunopathophysiology and potential therapeutic strategies

Vito Angelo Giagulli iD, Giuseppe Lisco iD, Anna De Tullio iD, Edoardo Guastamacchia iD, Vincenzo Triggiani iD, Emilio Jirillo iD

Sexual Medicine Reviews · 26.03.2024 · 12 (2) · 210-220

DOI: 10.1093/sxmrev/qead055 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Sexual Medicine Reviews, online erschienen am 09.01.2024. Verfasst von Vito Angelo Giagulli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Department of Medicine-Section of Internal Medicine, Geriatrics, Endocrinology, and Rare Diseases, School of Medicine, University o…. Hauptthemen laut MEDLINE: Erectile Dysfunction, Penile Induration. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Erectile dysfunction (ED) represents the major cause of male sexual dysfunction, which is often associated with obesity, diabetes mellitus, atherosclerotic cardiovascular disease, and cigarette smoking. Peyronie’s disease is a chronic disorder associated with irreversible fibrotic damage of the tunica albuginea leading to ED, painful erection, coital disturbance, and physical and social complaints. Both conditions are characterized by chronic inflammation, oxidative stress, and significant changes in intracavernous hydrodynamics. In this scenario, oxidized lipoproteins, M1-polarized macrophages, proinflammatory cytokines (such as the tumor necrosis factor α), endothelial nitric oxide synthase, penile smooth muscle cells, and toll-like receptors represent the main triggers of the inflammatory process in ED. Phosphodiesterase-5 inhibitors are the most common treatment for ED. This treatment is used intermittently, as it is conceived as a symptomatic and not curative therapy. Moreover, not all patients respond to phosphodiesterase-5 inhibitors (35%-85%), particularly those with dysmetabolic phenotypes. Additional or alternative treatments are therefore desirable, mostly in refractory cases.

Objectives

In this review, we describe the immune-mediated pathogenesis of ED and Peyronie’s disease (PD). In our literature search we placed particular emphasis on potentially practical therapeutic approaches, including natural products (such as polyphenols), due to their anti-inflammatory and antioxidant activities, stem cell therapy, and platelet-derived preparations.

Methods

We searched PubMed/MEDLINE, Web of Science, Scopus, Cochrane Library, Google Scholar, and institutional websites. Original studies, narrative reviews, systematic reviews, and meta-analyses written in English were searched, screened, and selected.

Results

In animal models of ED and PD, therapeutic approaches, including anti-inflammatory and antioxidant agents, stem cell therapy, and platelet-derived preparations, have provided positive results, including improved penile function, reduced inflammation and oxidative stress, and promotion of tissue repair. However, clinical evidence of improvement in human patients is still insufficient.

Conclusion

Promising results for treating ED and PD have been shown in preclinical and pilot clinical studies, but specific clinical trials are needed to validate the efficacy of these therapeutic approaches in men with ED.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erectile DysfunctionPenile IndurationAnimalsHumansMaleAntioxidantsCyclic Nucleotide Phosphodiesterases, Type 5InflammationImmune SystemAnti-Inflammatory Agents

Stichwörter der Autor:innen

Peyronie’s diseasecytokineserectile dysfunctionmacrophagesphosphodiesterase-5 inhibitorspolyphenolsstem cellstoll-like receptors

Substanzen

AntioxidantsCyclic Nucleotide Phosphodiesterases, Type 5Anti-Inflammatory Agents

Autor:innen und Institutionen

  • Interdisciplinary Department of Medicine-Section of Internal Medicine, Geriatrics, Endocrinology, and Rare Diseases, School of Medicine, University of Bari "Aldo Moro", Policlinico, Piazza Giulio Cesare 11, 70124 Bari,…

ORCID-Profile: Vito Angelo Giagulli, Giuseppe Lisco, Anna De Tullio, Edoardo Guastamacchia, Vincenzo Triggiani, Emilio Jirillo

Zitieren

APA

Giagulli, V. A., Lisco, G., De Tullio, A., Guastamacchia, E., Triggiani, V., & Jirillo, E. (2024). The pathogenic role of the immune system in erectile dysfunction and Peyronie’s disease: focusing on immunopathophysiology and potential therapeutic strategies. Sexual Medicine Reviews, 12(2), 210-220. https://doi.org/10.1093/sxmrev/qead055

Vancouver

Giagulli VA, Lisco G, De Tullio A, Guastamacchia E, Triggiani V, Jirillo E. The pathogenic role of the immune system in erectile dysfunction and Peyronie’s disease: focusing on immunopathophysiology and potential therapeutic strategies. Sexual Medicine Reviews. 2024;12(2):210-220. doi:10.1093/sxmrev/qead055

BibTeX
@article{Giagulli2024,
  author = {Giagulli, Vito Angelo and Lisco, Giuseppe and De Tullio, Anna and Guastamacchia, Edoardo and Triggiani, Vincenzo and Jirillo, Emilio},
  title = {The pathogenic role of the immune system in erectile dysfunction and Peyronie’s disease: focusing on immunopathophysiology and potential therapeutic strategies},
  journal = {Sexual Medicine Reviews},
  year = {2024},
  volume = {12},
  number = {2},
  pages = {210--220},
  doi = {10.1093/sxmrev/qead055}
}
Kostenlos starten →